209 related articles for article (PubMed ID: 19141040)
1. In vitro efficacy of the novel peptide CECT7121 against bacteria isolated from mastitic dairy cattle.
Sparo MD; Jones DG; Sánchez Bruni SF
Lett Appl Microbiol; 2009 Feb; 48(2):187-92. PubMed ID: 19141040
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
Sparo MD; Jones DG; Sánchez Bruni SF
Chemotherapy; 2009; 55(4):270-7. PubMed ID: 19494489
[TBL] [Abstract][Full Text] [Related]
3. Bactericidal Activity and Synergy Studies of Peptide AP-CECT7121 Against Multi-resistant Bacteria Isolated from Human and Animal Soft Tissue Infections.
Delpech G; Bistoletti M; Ceci M; Lissarrague S; Bruni SS; Sparo M
Probiotics Antimicrob Proteins; 2017 Sep; 9(3):355-362. PubMed ID: 28573492
[TBL] [Abstract][Full Text] [Related]
4. Distribution and antimicrobial resistance of clinical and subclinical mastitis pathogens in dairy cows in Rhône-Alpes, France.
Botrel MA; Haenni M; Morignat E; Sulpice P; Madec JY; Calavas D
Foodborne Pathog Dis; 2010 May; 7(5):479-87. PubMed ID: 19919286
[TBL] [Abstract][Full Text] [Related]
5. Relationship between results of in vitro susceptibility tests and outcomes following treatment with pirlimycin hydrochloride in cows with subclinical mastitis associated with gram-positive pathogens.
Apparao D; Oliveira L; Ruegg PL
J Am Vet Med Assoc; 2009 Jun; 234(11):1437-46. PubMed ID: 19480625
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
Chockalingam A; Zarlenga DS; Bannerman DD
Am J Vet Res; 2007 Nov; 68(11):1151-9. PubMed ID: 17975968
[TBL] [Abstract][Full Text] [Related]
7. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of mastitis pathogens of dairy cows in Switzerland.
Rüegsegger F; Ruf J; Tschuor A; Sigrist Y; Rosskopf M; Hässig M
Schweiz Arch Tierheilkd; 2014 Oct; 156(10):483-8. PubMed ID: 25273869
[TBL] [Abstract][Full Text] [Related]
9. Aminoglycoside-resistant Streptococcus and Enterococcus species isolated from bovine mammary secretions.
Jayarao BM; Oliver SP
J Dairy Sci; 1992 Apr; 75(4):991-7. PubMed ID: 1578037
[TBL] [Abstract][Full Text] [Related]
10. Antimicrobial susceptibility of udder pathogens from cases of acute clinical mastitis in dairy cows.
Bengtsson B; Unnerstad HE; Ekman T; Artursson K; Nilsson-Ost M; Waller KP
Vet Microbiol; 2009 Apr; 136(1-2):142-9. PubMed ID: 19058930
[TBL] [Abstract][Full Text] [Related]
11. Conventional identification of Streptococcus uberis isolated from bovine mastitis in Argentinean dairy herds.
Odierno L; Calvinho L; Traverssa P; Lasagno M; Bogni C; Reinoso E
J Dairy Sci; 2006 Oct; 89(10):3886-90. PubMed ID: 16960064
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial resistance in streptococcal species isolated from bovine mammary glands.
Brown MB; Scasserra AE
Am J Vet Res; 1990 Dec; 51(12):2015-8. PubMed ID: 2085229
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility of microorganisms isolated from the mammary glands of dairy heifers.
Watts JL; Salmon SA; Yancey RJ; Nickerson SC; Weaver LJ; Holmberg C; Pankey JW; Fox LK
J Dairy Sci; 1995 Jul; 78(7):1637-48. PubMed ID: 7593859
[TBL] [Abstract][Full Text] [Related]
14. Relationship between antimicrobial drug usage and antimicrobial susceptibility of gram-positive mastitis pathogens.
Pol M; Ruegg PL
J Dairy Sci; 2007 Jan; 90(1):262-73. PubMed ID: 17183094
[TBL] [Abstract][Full Text] [Related]
15. Antibacterial activity of thionin Thi2.1 from Arabidopsis thaliana expressed by bovine endothelial cells against Staphylococcus aureus isolates from bovine mastitis.
Ochoa-Zarzosa A; Loeza-Angeles H; Sagrero-Cisneros E; Villagómez-Gómez E; Lara-Zárate L; López-Meza JE
Vet Microbiol; 2008 Mar; 127(3-4):425-30. PubMed ID: 17961938
[TBL] [Abstract][Full Text] [Related]
16. Commensal bacilli inhibitory to mastitis pathogens isolated from the udder microbiota of healthy cows.
Al-Qumber M; Tagg JR
J Appl Microbiol; 2006 Nov; 101(5):1152-60. PubMed ID: 17040239
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of telavancin against recent Gram-positive clinical isolates: results of the 2004-05 Prospective European Surveillance Initiative.
Draghi DC; Benton BM; Krause KM; Thornsberry C; Pillar C; Sahm DF
J Antimicrob Chemother; 2008 Jul; 62(1):116-21. PubMed ID: 18424792
[TBL] [Abstract][Full Text] [Related]
18. Esculentin 1-21: a linear antimicrobial peptide from frog skin with inhibitory effect on bovine mastitis-causing bacteria.
Islas-Rodrìguez AE; Marcellini L; Orioni B; Barra D; Stella L; Mangoni ML
J Pept Sci; 2009 Sep; 15(9):607-14. PubMed ID: 19507197
[TBL] [Abstract][Full Text] [Related]
19. Xenorhabdus antibiotics: a comparative analysis and potential utility for controlling mastitis caused by bacteria.
Furgani G; Böszörményi E; Fodor A; Máthé-Fodor A; Forst S; Hogan JS; Katona Z; Klein MG; Stackebrandt E; Szentirmai A; Sztaricskai F; Wolf SL
J Appl Microbiol; 2008 Mar; 104(3):745-58. PubMed ID: 17976177
[TBL] [Abstract][Full Text] [Related]
20. Antimicrobial susceptibility of tigecycline and comparators against bacterial isolates collected as part of the TEST study in Europe (2004-2007).
Nørskov-Lauritsen N; Marchandin H; Dowzicky MJ
Int J Antimicrob Agents; 2009 Aug; 34(2):121-30. PubMed ID: 19342205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
